Fidelity Advisor Financials

FBTTX Fund  USD 28.27  0.35  1.25%   
Financial data analysis helps to check if markets are presently mispricing Fidelity Advisor Bio. We were able to interpolate and analyze data for sixteen available fundamental indicators for Fidelity Advisor Biotechnology, which can be compared to its rivals. Use Fidelity Advisor price to book, one year return, as well as the relationship between the One Year Return and cash position weight to make sure your decision on pricing Fidelity Advisor Bio is adequate. The fund experiences a large bullish trend. Check odds of Fidelity Advisor to be traded at $31.1 in 90 days.
With this module, you can analyze Fidelity financials for your investing period. You should be able to track the changes in Fidelity Advisor individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Fidelity Advisor Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Fidelity Advisor's financial statements are interrelated, with each one affecting the others. For example, an increase in Fidelity Advisor's assets may result in an increase in income on the income statement.
Evaluating Fidelity Advisor's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Fidelity Advisor's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Fidelity Advisor's relative financial performance

Chance Of Distress

Less than 35

 
100  
 
Zero
Below Average
Fidelity Advisor Biotechnology has less than 35 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Fidelity Advisor mutual fund is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
More Info
The data published in Fidelity Advisor's official financial statements usually reflect Fidelity Advisor's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Fidelity Advisor Bio. For example, before you start analyzing numbers published by Fidelity accountants, it's critical to develop an understanding of what Fidelity Advisor's liquidity, profitability, and earnings quality are in the context of the Fidelity Investments space in which it operates.
Please note that past performance is not an indicator of the future performance of Fidelity Advisor, its manager's success, or the effectiveness of its strategy. The performance results shown here may have been adversely or favorably impacted by events and economic conditions that may not prevail in the future. Therefore, you must use caution to infer that these results indicate any fund, manager, or strategy's future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost. .

Fidelity Advisor Company Summary

Fidelity Advisor competes with Vanguard Health, Coca Cola, SCOR PK, Franklin Strategic, and Barloworld. The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuers financial condition and industry position, as well as market and economic conditions, to select investments. The fund is non-diversified.
Specialization
Health, Large
InstrumentUSA Mutual Fund View All
ExchangeNMFQS Exchange
ISINUS3159184908
Business AddressFidelity Advisor Series
Mutual Fund FamilyFidelity Investments
Mutual Fund CategoryHealth
BenchmarkNYSE Composite
Phone877 208 0098
CurrencyUSD - US Dollar
You should never invest in Fidelity Advisor without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Fidelity Mutual Fund, because this is throwing your money away. Analyzing the key information contained in Fidelity Advisor's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Fidelity Advisor Key Financial Ratios

Generally speaking, Fidelity Advisor's financial ratios allow both analysts and investors to convert raw data from Fidelity Advisor's financial statements into concise, actionable information that can be used to evaluate the performance of Fidelity Advisor over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Fidelity Advisor Bio reports annually and quarterly.

Fidelity Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fidelity Advisor's current stock value. Our valuation model uses many indicators to compare Fidelity Advisor value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fidelity Advisor competition to find correlations between indicators driving Fidelity Advisor's intrinsic value. More Info.
Fidelity Advisor Biotechnology is one of the top funds in cash position weight among similar funds. It is one of the top funds in five year return among similar funds reporting about  13.93  of Five Year Return per Cash Position Weight. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fidelity Advisor by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fidelity Advisor's Mutual Fund . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fidelity Advisor's earnings, one of the primary drivers of an investment's value.

Fidelity Advisor Bio Systematic Risk

Fidelity Advisor's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Fidelity Advisor volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Fidelity Advisor Bio correlated with the market. If Beta is less than 0 Fidelity Advisor generally moves in the opposite direction as compared to the market. If Fidelity Advisor Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fidelity Advisor Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fidelity Advisor is generally in the same direction as the market. If Beta > 1 Fidelity Advisor moves generally in the same direction as, but more than the movement of the benchmark.

About Fidelity Advisor Financials

What exactly are Fidelity Advisor Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Fidelity Advisor's income statement, its balance sheet, and the statement of cash flows. Potential Fidelity Advisor investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Fidelity Advisor investors may use each financial statement separately, they are all related. The changes in Fidelity Advisor's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fidelity Advisor's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Fidelity Advisor Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Fidelity Advisor is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Fidelity has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Fidelity Advisor's financials are consistent with your investment objective using the following steps:
  • Review Fidelity Advisor's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Fidelity Advisor's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Fidelity Advisor's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Fidelity Advisor's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Fidelity Advisor Thematic Clasifications

Fidelity Advisor Biotechnology is part of Monster Funds investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Funds with above average long term performance indicators. Solid funds with above average long term performance indicators based on Macroaxis rating system
Monster FundsView
This theme covers Funds with above average long term performance indicators. Solid funds with above average long term performance indicators based on Macroaxis rating system. Get More Thematic Ideas
Fidelity Advisor Biotechnology is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of Health category is currently estimated at about 255.15 Billion. Fidelity Advisor claims roughly 2.85 Billion in net asset contributing just under 2% to all funds under Health category.

Fidelity Advisor March 28, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Fidelity Advisor help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Fidelity Advisor Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fidelity Advisor Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Fidelity Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fidelity Advisor's daily price indicators and compare them against related drivers.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fidelity Advisor Biotechnology. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Fidelity Mutual Fund analysis

When running Fidelity Advisor's price analysis, check to measure Fidelity Advisor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fidelity Advisor is operating at the current time. Most of Fidelity Advisor's value examination focuses on studying past and present price action to predict the probability of Fidelity Advisor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fidelity Advisor's price. Additionally, you may evaluate how the addition of Fidelity Advisor to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Please note, there is a significant difference between Fidelity Advisor's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fidelity Advisor is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fidelity Advisor's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.